| Document |
Document Title |
|
WO/2022/117111A1 |
Disclosed are a salt of a pyrrolopyrimidine compound, a crystalline form thereof, and an application thereof. Specifically provided are a crystal form of the compound represented by the formula I, a salt thereof, and a hydrate of the sal...
|
|
WO/2022/114545A1 |
The present application relates to a process for producing acrylic acid.
|
|
WO/2022/114546A1 |
The present application relates to a process for producing acrylic acid.
|
|
WO/2022/109716A1 |
It is provided a process of converting syngas resulting from the gasification of a carbonaceous material into acetic acid and acrylic acid comprising converting the syngas into methanol and separating the methanol into a first and second...
|
|
WO/2022/114519A1 |
The present invention relates to a method for producing a catalyst for dehydrogenation of 3-hydroxypropionic acid, a catalyst for dehydrogenation of 3-hydroxypropionic acid, and a method for producing acrylic acid using the catalyst.
|
|
WO/2022/107812A1 |
The present invention relates to a compound purification device having a crystallizer in which N crystallization tanks are connected in series, and a cleaning column for forcibly transporting crystals, wherein the cleaning column has a l...
|
|
WO/2022/107813A1 |
The present invention pertains to a method for purifying a compound using a purification apparatus having a crystallizer, in which N crystallization tanks are connected in series, and a cleaning column which forcibly transports crystals,...
|
|
WO/2022/106158A1 |
The invention relates to a process for preparing α,β-ethylenically unsaturated carboxylic acids by two-stage catalytic gas phase oxidation of alkenes, in which a gas stream (1) containing at least one alkene, in a first reactor (A) in ...
|
|
WO/2022/106551A1 |
The present invention relates to co-crystal forms of the following compound (I).
|
|
WO/2022/107865A1 |
[Problem] To provide a 11C-labelled acyclic retinoid that can be efficiently synthesized in a short amount of time and is suited to elucidating intracerebral kinetics using PET, a PET probe that uses the retinoid, and production methods ...
|
|
WO/2022/108945A1 |
The present disclosure relates to 1,4-benzothiazepine derivatives and use thereof to treat conditions associated with ryanodine receptors that regulate calcium channel functioning in cells.
|
|
WO/2022/103087A1 |
The present invention relates to a method for preparing acrylic acid and, more particularly, to a method for preparing acrylic acid by dehydrating lactic acid molecules. According to the preparation method of the present invention, it is...
|
|
WO/2022/099439A1 |
A preparation method for 2,4,5-trifluorophenylacetic acid, comprising: step one, reacting raw materials, a quaternary ammonium salt catalyst, sulfolane and potassium fluoride to obtain a first intermediate; step two, subjecting the first...
|
|
WO/2022/098757A1 |
Provided are HSD17B13 substrates, reaction products, kits, and methods that include the HSD17B13 substrates or reaction products of the HSD17B13 substrates. Some embodiments include methods of treatment. Some such embodiments include det...
|
|
WO/2022/098881A1 |
Disclosed are compounds and methods to enhance the resolution of inflammation and inflammatory diseases comprising novel compounds derived from conjugated specialized pro-resolving lipid mediators (SPMs). These compounds are useful in pr...
|
|
WO/2022/094339A1 |
Described herein are methods of preparing compounds derived from triglycerides or condensation polymers such as polyesters and/or polyamides. The methods may include subjecting triglyceride or condensation polymer containing matter to me...
|
|
WO/2022/084046A1 |
The present invention relates to a process for preparing methyl methacrylate (MMA) and/or methacrylic acid (MAS) with improved yield, comprising the process steps of amidation, conversion and hydrolysis/esterification, especially high yi...
|
|
WO/2022/084032A1 |
The invention relates to an improved process for synthesizing alkyl methacrylates, in particular methyl methacrylate (MMA), involving reacting acetone cyanohydrin (ACH) and sulfuric acid in a first reaction stage (amidation) and heating ...
|
|
WO/2022/080905A1 |
The present specification relates to an apparatus for vaporizing lactic acid. According to a method and an apparatus for vaporizing lactic acid, of the present invention, the quantity of lactic acid oligomers can be reduced within a shor...
|
|
WO/2022/080642A1 |
The present application relates to a manufacturing method for a molybdenum-bismuth composite metal oxide.
|
|
WO/2022/065116A1 |
A catalyst precursor that has an average particle diameter (D50), being the particle diameter at which the cumulative volume fraction reaches 50%, of 10–40 μm and is indicated by formula (1). Moa1Bib1Nic1Cod1Fee1Xf1Yg1Zh1Oi1 ... (1)...
|
|
WO/2022/054842A1 |
The present invention provides a method for safely and stably obtaining a product of high quality. The present invention provides a method for producing a compound, said method comprising: a step wherein a slurry that contains crystals o...
|
|
WO/2022/054840A1 |
The present invention provides a method for obtaining high-quality products. The purification device according to the present invention is for purifying crystals. The purification device is configured to include: a hydraulic washing colu...
|
|
WO/2022/054841A1 |
The present invention provides a method capable of adequately reducing impurities and obtaining excellent separation efficiency thereof, even in a slurry having low purity of the mother liquor that includes crystals having poor solid-liq...
|
|
WO/2022/050110A1 |
This catalyst for producing an acrylic acid from acrolein contains, as a catalytically active component thereof, molybdenum, vanadium, and copper. The catalytically active component has diffraction peaks, in an X-ray diffraction analysis...
|
|
WO/2022/043874A1 |
The present invention provides a method of treating a locus against pest infestation using a compound of Formula I as described herein or an agriculturally acceptable salt thereof. The present invention also provides combinations and com...
|
|
WO/2022/039144A1 |
A compound represented by the formula, a method for producing the same, and the use of the compound. Ring Ar1 and ring Ar2 represent an aromatic ring represented by a specific formula or a condensed ring thereof, and R1 and R2 represent ...
|
|
WO/2022/033417A1 |
The present invention relates to a fullerene aryl polycarboxylic acid derivative and the use thereof in preventing coronavirus infections. Specifically provided are a compound represented by formula A: fullerene-RR1R2R3R4R5 Formula A, or...
|
|
WO/2022/033563A1 |
The present application relates to a JAK inhibitor compound and use thereof. Specifically, disclosed in the present application is a compound in a solid form as shown in formula (I), or an isotopically labeled compound thereof, or an opt...
|
|
WO/2022/032269A1 |
A process for the treatment of sulfidic spent caustic, conditioned catalyst regeneration vent gas, C4 isomerization off gas, various and hydrocarbon containing liquid and gaseous streams in addition to toxic containing streams like cyani...
|
|
WO/2022/020940A1 |
The present invention provides novel salts of remdesivir and crystalline forms thereof. Specific salts of remdesivir provided by the present invention include napsylate, tosylate, hydrochloride, phosphate, maleate, and oxalate. Also prov...
|
|
WO/2022/020963A1 |
A method for the synthesis of specialized pro-resolving mediators, structural isomers thereof and analogs thereof is disclosed herein. The method comprises reacting a compound of the formula (I): (I) wherein R1 is alkyl(C≤12), cycloalk...
|
|
WO/2022/022398A1 |
Provided are a salt and a crystal form of a pyrimidine compound, and preparation methods therefor. Specifically, provided are a salt and a crystal form of a compound I, covering a crystal form of the salt, and preparation methods therefor.
|
|
WO/2022/023291A1 |
Method for the purification of vilanterol trifenatate It is provided a method for the purification of vilanterol trifenatate of formula (I) comprising crystallizing vilanterol trifenatate from a ketone solvent selected from the group con...
|
|
WO/2022/019336A1 |
The purpose of the present invention is to provide: a novel deuterated labeling compound; and a production method therefor. The present invention provides: a deuterated labeling compound in which at least position β of a fatty acid is d...
|
|
WO/2021/262043A1 |
Components of bioluminescent systems are widely used reagents for a large number of assays, including diagnostic systems, quality control systems, drug trial systems and the like. The present group of inventions discloses components of t...
|
|
WO/2021/262814A1 |
The invention relates to novel crystalline forms of imiquimod formed with ferulic acid, acetic acid, coumaric acid, citric acid, or tartaric acid, to methods of making these cocrystals, and to compositions containing the cocrystals.
|
|
WO/2021/257717A1 |
Described herein are methods for the preparation of bio-based acrylic acid from bio-based methyl lactate. Some methods involve the use of an azeotropic distillate of methyl acrylate and methanol. The methods enhance bio-based acrylic aci...
|
|
WO/2021/252630A1 |
Described herein are methods for treating or preventing chronic kidney disease, and other diseases, comprising the administration (3,5-dibromo-4-hydroxyphenyl)(2-(1-hydroxyethyl)benzofuran-3
-yl-4,5,6,7-d4)methanone, and solvates thereof.
|
|
WO/2021/246368A1 |
A method for producing an easily polymerizable compound, said method comprising a polymerization prevention step wherein an oxygen-containing gas is supplied to an easily polymerizable compound-containing liquid through a gas supply mean...
|
|
WO/2021/246355A1 |
A method for producing an easily polymerizable compound, said method comprising a step for purifying an easily polymerizable compound-containing liquid by introducing the easily polymerizable compound-containing liquid into a vaporizatio...
|
|
WO/2021/240547A2 |
The present invention relates to process for preparation of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxy imino]ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid, intermediates, salts and solid forms thereof to pharmaceutical co...
|
|
WO/2021/233839A1 |
The present invention relates to a method for preparing acrylic acid from β-propriolactane and to the uses thereof. The process of the invention is based on a specific reactivity of β-propriolactane whereby acrylic acid is formed under...
|
|
WO/2021/234249A1 |
The present invention relates to an improved method for regeneration, by thermal cracking, of a mixture of heavy by-products (residues) originating from an acrylic acid production unit and an acrylic ester production unit, leading to the...
|
|
WO/2021/223398A1 |
Provided in the present invention is a crystal form for treating a liver disease of tenofovir phosphate(9-[(2R)-2-[(2R,4S)-4-(3-chlorophenyl)-2-oxo-1,3,2-
dioxaphosphorinane-2-methoxy]propyl]adenine fumarate), paladovir mesylate((+)-cis-...
|
|
WO/2021/224044A1 |
The present invention relates to a method for breaking down Michael adducts of acrylic acid, which adducts are contained in a fluid F, in a breakdown apparatus which comprises at least one separating column K, an evaporator V and a pump ...
|
|
WO/2021/219387A1 |
The present invention relates to the use of strobilurin type compounds of formula I and the N-oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome b ...
|
|
WO/2021/219386A1 |
The present invention relates to the use of strobilurin type compounds of formula I and the N-oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome b ...
|
|
WO/2021/219388A1 |
The present invention relates to the use of strobilurin type compounds of formula I and the N-oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome b ...
|
|
WO/2021/219390A1 |
The present invention relates to the use of strobilurin type compounds of formula I and the N-oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome b ...
|
